ANDA 71619, held by Hospira. Ritodrine Hydrochloride.
As of Nov 16, 2026, ANDA 71619 (Ritodrine Hydrochloride), held by Hospira, was first approved by FDA on Feb 28, 1991, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 28, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ritodrine Hydrochloride15MG/ML ยท injectable;injection | Ritodrine Hydrochloride | Discontinued |
| Mar 9, 1998 | Supplement 7Labeling | Approved | None posted |
| Oct 22, 1996 | Supplement 4Manufacturing | Approved | None posted |
| Oct 3, 1996 | Supplement 5Manufacturing | Approved | None posted |
| Sep 5, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Oct 8, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Feb 28, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters